A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 396 participants.

Also called NCT02749994

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 396 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02749994
Other papers using this trial's data
  • A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial Clinical therapeutics, 2018-02 DOI, PubMed 29402522

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02749994. Randomized; double masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2017-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
Acronym
I-ROSETTE
Condition
Hypercholesterolemia
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Ezetimibe
Lead sponsor
IlDong Pharmaceutical Co Ltd (class: industry)

Record details

Record id
cardio:ct-nct02749994
Content hash
70a41371053ed5eb4fe987acd128f9fdee186480065aef5a6ccb1a1ef36842e9